ClinicalTrials.govpublic full text
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
microsatellite-stable colorectal cancer, standard of care, nivolumab, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.